Global Nuclear Medicine Diagnostic Equipment Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global Nuclear Medicine Diagnostic Equipment market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Nuclear Medicine Diagnostic Equipment market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Nuclear Medicine Diagnostic Equipment market include GE HealthCare, Siemens Healthineers, CMR Naviscan, Compañía Mexicana, DDD-Diagnostic, Digirad, Mediso Medical Imaging Systems, Philips and Positron, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nuclear Medicine Diagnostic Equipment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Nuclear Medicine Diagnostic Equipment, also provides the sales of main regions and countries. Of the upcoming market potential for Nuclear Medicine Diagnostic Equipment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nuclear Medicine Diagnostic Equipment sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Nuclear Medicine Diagnostic Equipment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Nuclear Medicine Diagnostic Equipment sales, projected growth trends, production technology, application and end-user industry.

Nuclear Medicine Diagnostic Equipment Segment by Company

GE HealthCare
Siemens Healthineers
CMR Naviscan
Compañía Mexicana
DDD-Diagnostic
Digirad
Mediso Medical Imaging Systems
Philips
Positron
SurgicEye
TeraRecon
Toshiba
Top Grade Healthcare
Neusoft Group
United Imaging
MinFound Medical
SinoUnion Healthcare
Nuclear Medicine Diagnostic Equipment Segment by Type

PET
SPECT
Nuclear Medicine Diagnostic Equipment Segment by Application

Tumor Imaging
Endocrine System Imaging
Urinary System Imaging
Bone Marrow Imaging
Others
Nuclear Medicine Diagnostic Equipment Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Nuclear Medicine Diagnostic Equipment status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Nuclear Medicine Diagnostic Equipment market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Nuclear Medicine Diagnostic Equipment significant trends, drivers, influence factors in global and regions.
6. To analyze Nuclear Medicine Diagnostic Equipment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Diagnostic Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Diagnostic Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Diagnostic Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nuclear Medicine Diagnostic Equipment market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nuclear Medicine Diagnostic Equipment industry.
Chapter 3: Detailed analysis of Nuclear Medicine Diagnostic Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Nuclear Medicine Diagnostic Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Nuclear Medicine Diagnostic Equipment in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Nuclear Medicine Diagnostic Equipment Sales Value (2020-2031)
1.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume (2020-2031)
1.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Nuclear Medicine Diagnostic Equipment Market Dynamics
2.1 Nuclear Medicine Diagnostic Equipment Industry Trends
2.2 Nuclear Medicine Diagnostic Equipment Industry Drivers
2.3 Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges
2.4 Nuclear Medicine Diagnostic Equipment Industry Restraints
3 Nuclear Medicine Diagnostic Equipment Market by Company
3.1 Global Nuclear Medicine Diagnostic Equipment Company Revenue Ranking in 2024
3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Company (2020-2025)
3.3 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Company (2020-2025)
3.4 Global Nuclear Medicine Diagnostic Equipment Average Price by Company (2020-2025)
3.5 Global Nuclear Medicine Diagnostic Equipment Company Ranking (2023-2025)
3.6 Global Nuclear Medicine Diagnostic Equipment Company Manufacturing Base and Headquarters
3.7 Global Nuclear Medicine Diagnostic Equipment Company Product Type and Application
3.8 Global Nuclear Medicine Diagnostic Equipment Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Nuclear Medicine Diagnostic Equipment Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Nuclear Medicine Diagnostic Equipment Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Nuclear Medicine Diagnostic Equipment Market by Type
4.1 Nuclear Medicine Diagnostic Equipment Type Introduction
4.1.1 PET
4.1.2 SPECT
4.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type
4.2.1 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type (2020-2031)
4.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Type (2020-2031)
4.3 Global Nuclear Medicine Diagnostic Equipment Sales Value by Type
4.3.1 Global Nuclear Medicine Diagnostic Equipment Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Type (2020-2031)
4.3.3 Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Type (2020-2031)
5 Nuclear Medicine Diagnostic Equipment Market by Application
5.1 Nuclear Medicine Diagnostic Equipment Application Introduction
5.1.1 Tumor Imaging
5.1.2 Endocrine System Imaging
5.1.3 Urinary System Imaging
5.1.4 Bone Marrow Imaging
5.1.5 Others
5.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application
5.2.1 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application (2020-2031)
5.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Application (2020-2031)
5.3 Global Nuclear Medicine Diagnostic Equipment Sales Value by Application
5.3.1 Global Nuclear Medicine Diagnostic Equipment Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Application (2020-2031)
5.3.3 Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Application (2020-2031)
6 Nuclear Medicine Diagnostic Equipment Regional Sales and Value Analysis
6.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region (2020-2031)
6.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2020-2025
6.2.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region (2026-2031)
6.3 Global Nuclear Medicine Diagnostic Equipment Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Nuclear Medicine Diagnostic Equipment Sales Value by Region (2020-2031)
6.4.1 Global Nuclear Medicine Diagnostic Equipment Sales Value by Region: 2020-2025
6.4.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Region (2026-2031)
6.5 Global Nuclear Medicine Diagnostic Equipment Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Nuclear Medicine Diagnostic Equipment Sales Value (2020-2031)
6.6.2 North America Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Nuclear Medicine Diagnostic Equipment Sales Value (2020-2031)
6.7.2 Europe Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Value (2020-2031)
6.8.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Nuclear Medicine Diagnostic Equipment Sales Value (2020-2031)
6.9.2 South America Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Value (2020-2031)
6.10.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2024 VS 2031
7 Nuclear Medicine Diagnostic Equipment Country-level Sales and Value Analysis
7.1 Global Nuclear Medicine Diagnostic Equipment Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2031)
7.3.1 Global Nuclear Medicine Diagnostic Equipment Sales by Country (2020-2025)
7.3.2 Global Nuclear Medicine Diagnostic Equipment Sales by Country (2026-2031)
7.4 Global Nuclear Medicine Diagnostic Equipment Sales Value by Country (2020-2031)
7.4.1 Global Nuclear Medicine Diagnostic Equipment Sales Value by Country (2020-2025)
7.4.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.5.2 USA Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.6.2 Canada Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.8.2 Germany Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.9.2 France Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.9.3 France Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.11.2 Italy Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.12.2 Spain Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.13.2 Russia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.16.2 China Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.16.3 China Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.17.2 Japan Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.19.2 India Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.19.3 India Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.20.2 Australia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.24.2 Chile Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.26.2 Peru Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.28.2 Israel Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.29.2 UAE Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.31.2 Iran Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 GE HealthCare
8.1.1 GE HealthCare Comapny Information
8.1.2 GE HealthCare Business Overview
8.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio
8.1.5 GE HealthCare Recent Developments
8.2 Siemens Healthineers
8.2.1 Siemens Healthineers Comapny Information
8.2.2 Siemens Healthineers Business Overview
8.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio
8.2.5 Siemens Healthineers Recent Developments
8.3 CMR Naviscan
8.3.1 CMR Naviscan Comapny Information
8.3.2 CMR Naviscan Business Overview
8.3.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.3.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio
8.3.5 CMR Naviscan Recent Developments
8.4 Compañía Mexicana
8.4.1 Compañía Mexicana Comapny Information
8.4.2 Compañía Mexicana Business Overview
8.4.3 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.4.4 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio
8.4.5 Compañía Mexicana Recent Developments
8.5 DDD-Diagnostic
8.5.1 DDD-Diagnostic Comapny Information
8.5.2 DDD-Diagnostic Business Overview
8.5.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.5.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio
8.5.5 DDD-Diagnostic Recent Developments
8.6 Digirad
8.6.1 Digirad Comapny Information
8.6.2 Digirad Business Overview
8.6.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.6.4 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio
8.6.5 Digirad Recent Developments
8.7 Mediso Medical Imaging Systems
8.7.1 Mediso Medical Imaging Systems Comapny Information
8.7.2 Mediso Medical Imaging Systems Business Overview
8.7.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.7.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio
8.7.5 Mediso Medical Imaging Systems Recent Developments
8.8 Philips
8.8.1 Philips Comapny Information
8.8.2 Philips Business Overview
8.8.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.8.4 Philips Nuclear Medicine Diagnostic Equipment Product Portfolio
8.8.5 Philips Recent Developments
8.9 Positron
8.9.1 Positron Comapny Information
8.9.2 Positron Business Overview
8.9.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.9.4 Positron Nuclear Medicine Diagnostic Equipment Product Portfolio
8.9.5 Positron Recent Developments
8.10 SurgicEye
8.10.1 SurgicEye Comapny Information
8.10.2 SurgicEye Business Overview
8.10.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.10.4 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio
8.10.5 SurgicEye Recent Developments
8.11 TeraRecon
8.11.1 TeraRecon Comapny Information
8.11.2 TeraRecon Business Overview
8.11.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.11.4 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio
8.11.5 TeraRecon Recent Developments
8.12 Toshiba
8.12.1 Toshiba Comapny Information
8.12.2 Toshiba Business Overview
8.12.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.12.4 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio
8.12.5 Toshiba Recent Developments
8.13 Top Grade Healthcare
8.13.1 Top Grade Healthcare Comapny Information
8.13.2 Top Grade Healthcare Business Overview
8.13.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.13.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
8.13.5 Top Grade Healthcare Recent Developments
8.14 Neusoft Group
8.14.1 Neusoft Group Comapny Information
8.14.2 Neusoft Group Business Overview
8.14.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.14.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio
8.14.5 Neusoft Group Recent Developments
8.15 United Imaging
8.15.1 United Imaging Comapny Information
8.15.2 United Imaging Business Overview
8.15.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.15.4 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio
8.15.5 United Imaging Recent Developments
8.16 MinFound Medical
8.16.1 MinFound Medical Comapny Information
8.16.2 MinFound Medical Business Overview
8.16.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.16.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio
8.16.5 MinFound Medical Recent Developments
8.17 SinoUnion Healthcare
8.17.1 SinoUnion Healthcare Comapny Information
8.17.2 SinoUnion Healthcare Business Overview
8.17.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2020-2025)
8.17.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
8.17.5 SinoUnion Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Nuclear Medicine Diagnostic Equipment Value Chain Analysis
9.1.1 Nuclear Medicine Diagnostic Equipment Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Nuclear Medicine Diagnostic Equipment Sales Mode & Process
9.2 Nuclear Medicine Diagnostic Equipment Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Nuclear Medicine Diagnostic Equipment Distributors
9.2.3 Nuclear Medicine Diagnostic Equipment Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings